Routine Infant Hepatitis B Vaccination Fails to Protect Into Young Adulthood

Broadcast Message

In 1991, the ACIP recommended hepatitis B vaccination for U.S. infants to prevent mother-to-child transmission. The CDC advises three doses: at birth, 1-2 months, and 6-18 months. A study found only 6.9% of soon-to-be medical students had lasting immunity, indicating the early vaccine may be less valuable for healthy infants without risk factors.

Link
https://petermcculloughmd.substack.com/p/routine-infant-hepatitis-b-vaccination

Routine Infant Hepatitis B Vaccination Fails to Protect Into Young Adulthood Parents Should Not Expect a Long-Term Benefit Mon, 12 Aug 2024 09:21:55 GMT https://petermcculloughmd.substack.com/p/routine-infant-hepatitis-b-vaccination By Peter A. McCullough, MD, MPH

In 1991, the Advisory Committee on Immunization Practices (ACIP) first recommended that all infants in the United States receive the hepatitis B vaccine at birth or within 1–2 months of age . The goal was to prevent maternal transmission of the hepatitis B virus (HBV) and reduce the incidence of infections in babies. Many healthy mothers without hepatitis B or risk factors such as IV drug abuse with normal infants ask what is the benefit in their babies?

The CDC recommends that children receive three doses of the hepatitis B vaccine as part of their routine childhood vaccine schedule:

First dose: Within 24 hours of birth

Second dose: Between 1–2 months of age

Third dose: Between 6–18 months of age

What happens later in life when young people go into the medical field and are potentially exposed to hepatitis B in sick patients? Posuwan et al evaluated a prospective cohort of young people (mean age 18 years) going into medicine and evaluated their antibody titers as a proxy of enduring immunity to hepatitis B.

Posuwan N, Vorayingyong A, Jaroonvanichkul V, Wasitthankasem R, Wanlapakorn N, Vongpunsawad S, Poovorawan Y. Implementation of hepatitis B vaccine in high-risk young adults with waning immunity. PLoS One. 2018 Aug 20;13(8):e0202637. doi: 10.1371/journal.pone.0202637. PMID: 30125298; PMCID: PMC6101408.

The investigators were disappointed to find that only 6.9% had long-lasting immunity to hepatitis B, and thus underwent booster doses upon entering medical school. It is unclear when immunity is lost in this cohort. The results are important for parents to understand that the hepatitis B shots given at birth are only applicable if the mother has hepatitis B or serious risks for carrying it including active IV drug abuse. Otherwise the vaccine schedule for this illness has little value at that age.

Courageous Discourse™ with Dr. Peter McCullough & John Leake is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

Please subscribe to Courageous Discourse as a paying ($5 monthly) or founder member so we can continue to bring you the truth.

Peter A. McCullough, MD, MPH

President, McCullough Foundation

www.mcculloughfnd.org